Financings In Brief: Pharmacyclics
Executive Summary
Pharmacyclics: Files registration with SEC for offering of 2 mil. shares of common stock and an over-allotment option of up to 300,000 additional shares. Morgan Stanley, Cowen & Co. and Invemed Associates are underwriting the proposed offering. Sunnyvale, Calif.-based Pharmacyclics is awaiting FDA approval of Gadolite suspension for imaging the gastrointestinal tract and has two products in development, GD-Tex and Lu-Tex...